Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of KPS-0373 compared to placebo in patients with Spinocerebellar Degeneration (SCD).


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01384435
Study type Interventional
Source Kissei Pharmaceutical Co., Ltd.
Contact
Status Completed
Phase Phase 2

See also
  Status Clinical Trial Phase
Recruiting NCT04779671 - Effects of the Fully Immersive VR Cognitive Training Based on Leisure Activities for the Elderly With MCI and SCD. N/A
Completed NCT02065596 - Hematopoietic Stem Cell Transplant for Sickle Cell Disease Phase 1
Enrolling by invitation NCT03655223 - Early Check: Expanded Screening in Newborns
Recruiting NCT03926351 - High Dose Omega 3 in People at Risk for Dementia Phase 2
Recruiting NCT05604547 - Exploring Near Infrared Spectroscopy (NIRS) Technologies for Assessment of Muscle Physiology, Tissue Oxygenation, and Blood Flow in Patients With Sickle Cell Disease (SCD) N/A
Recruiting NCT06335836 - The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function in SCD (Subjective Cognitive Decline, SCD)
Not yet recruiting NCT05682469 - Effects and Mechanism of the Fully Immersive Virtual Reality Cognitive Training Based on Leisure Activities N/A
Recruiting NCT06120361 - The Swedish BioFINDER - Primary Care Study
Recruiting NCT06122415 - The Swedish BioFINDER - Memory Clinic Study